Bank of New York Mellon Corp lessened its stake in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 2.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 429,287 shares of the business services provider's stock after selling 12,580 shares during the quarter. Bank of New York Mellon Corp owned 0.85% of Exponent worth $38,249,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently modified their holdings of the stock. JPMorgan Chase & Co. lifted its position in Exponent by 63.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider's stock worth $72,701,000 after acquiring an additional 245,086 shares in the last quarter. Geode Capital Management LLC boosted its position in Exponent by 4.8% in the 3rd quarter. Geode Capital Management LLC now owns 1,505,652 shares of the business services provider's stock valued at $173,597,000 after buying an additional 69,099 shares during the last quarter. Barclays PLC grew its stake in shares of Exponent by 219.0% during the third quarter. Barclays PLC now owns 96,526 shares of the business services provider's stock valued at $11,127,000 after acquiring an additional 66,263 shares in the last quarter. TimesSquare Capital Management LLC increased its position in shares of Exponent by 22.4% during the fourth quarter. TimesSquare Capital Management LLC now owns 342,850 shares of the business services provider's stock worth $30,548,000 after acquiring an additional 62,760 shares during the last quarter. Finally, DF Dent & Co. Inc. increased its position in shares of Exponent by 26.8% during the third quarter. DF Dent & Co. Inc. now owns 225,394 shares of the business services provider's stock worth $25,983,000 after acquiring an additional 47,573 shares during the last quarter. Hedge funds and other institutional investors own 92.37% of the company's stock.
Exponent Price Performance
EXPO traded down $1.44 on Monday, reaching $84.10. The company's stock had a trading volume of 555,065 shares, compared to its average volume of 267,826. The stock has a market cap of $4.27 billion, a price-to-earnings ratio of 39.67 and a beta of 0.77. The business's 50 day moving average is $89.14 and its 200 day moving average is $98.16. Exponent, Inc. has a 1 year low of $77.21 and a 1 year high of $115.75.
Exponent (NASDAQ:EXPO - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.46 EPS for the quarter, beating analysts' consensus estimates of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same quarter in the prior year, the business posted $0.41 EPS. As a group, research analysts forecast that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.
Exponent Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Friday, March 7th will be paid a dividend of $0.30 per share. The ex-dividend date is Friday, March 7th. This represents a $1.20 annualized dividend and a yield of 1.43%. This is a boost from Exponent's previous quarterly dividend of $0.28. Exponent's dividend payout ratio is presently 56.60%.
Insider Activity
In other Exponent news, VP Richard Reiss sold 1,736 shares of Exponent stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total value of $149,174.48. Following the completion of the transaction, the vice president now owns 1,800 shares of the company's stock, valued at $154,674. The trade was a 49.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 2.10% of the company's stock.
About Exponent
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.